Shikimate Kinase (EC 2.7.1.71) from Mycobacterium tuberculosis: Kinetics and Structural Dynamics of a Potential Molecular Target for Drug Development

Publisher： Bentham Science Publishers

E-ISSN： 1875-533x|18|9|1299-1310

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.18, Iss.9, 2011-03, pp. : 1299-1310

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Shikimate Kinase: A Potential Target for Development of Novel Antitubercular Agents

By  

Current Drug Targets, Vol. 8, Iss. 3, 2007-03 ,pp. : 459-468

Bentham Science Publishers

Access to resources Recommend Favorite

Purine Metabolism in Mycobacterium tuberculosis as a Target for Drug Development

By  

Current Pharmaceutical Design, Vol. 13, Iss. 6, 2007-02 ,pp. : 599-608

Bentham Science Publishers

Access to resources Recommend Favorite

Shikimate Kinase, a Protein Target for Drug Design

By  

Current Medicinal Chemistry, Vol. 21, Iss. 5, 2014-02 ,pp. : 592-604

Bentham Science Publishers

Access to resources Recommend Favorite

New tuberculosis drug development: targeting the shikimate pathway

By Kapnick Senta M   Zhang Ying  

Expert Opinion on Drug Discovery, Vol. 3, Iss. 5, 2008-05 ,pp. : 565-577

Informa Healthcare

Access to resources Recommend Favorite

The &bgr;-Ketoacyl-ACP Synthase from Mycobacterium tuberculosis as Potential Drug Targets

By  

Current Medicinal Chemistry, Vol. 18, Iss. 9, 2011-03 ,pp. : 1318-1324

Bentham Science Publishers

Access to resources Recommend Favorite